Gordon A. McLorie, MD, FRCSC, FAAP, CAQ

This is particularly the case when necrotic cells have elicited an acute inflammatory response (see Chapter 2) antibiotics effective against strep throat trusted 960 mg trimethoprim. Whereas the morphologic features of individual cell death tend to be uniform across different cell types antimicrobial jewelry buy trimethoprim 480 mg free shipping, the tissue responses are more variable antibiotics yeast infection prevention 960 mg trimethoprim buy. This diversity is described by several terms that reflect specific histologic patterns that depend on the organ and the circumstances antibiotics ointment for acne order trimethoprim with a mastercard. The unique feature determining this type of necrosis is the presence of triglycerides in adipose tissue finished antibiotics for uti still have symptoms trimethoprim 480 mg low cost. The process begins when digestive enzymes, normally found only in the pancreatic duct and small intestine, are released from injured pancreatic acinar cells and ducts into the extracellular spaces. On extracellular activation, these enzymes digest the pancreas itself as well as surrounding tissues, including adipose cells. Free fatty acids produced by pancreatic lipases bind calcium and are precipitated as calcium soaps. Traumatic fat necrosis is common in the breast where it may be mistaken for cancer. Caseous Necrosis Liquefactive Necrosis When the rate of dissolution of the necrotic cells is considerably faster than the rate of repair, the resulting morphologic appearance is termed liquefactive necrosis. The polymorphonuclear leukocytes of the acute inflammatory reaction contain potent hydrolases capable of digesting dead cells. A sharply localized collection of these acute infl ammatory cells, generally in response to bacterial infection, produces rapid cell death and tissue dissolution. Eventually, an abscess is walled off by a fibrous capsule that contains its contents. Coagulative necrosis of the brain may occur after cerebral artery occlusion and is followed by rapid dissolution- liquefactive necrosis-of the dead tissue by a mechanism that cannot be attributed to the action of an acute inflammatory response. Liquefactive necrosis of large areas of the central nervous system can lead to an actual cavity or cyst that persists permanently. The lesions of tuberculosis are compact aggregates of macrophages and other inflammatory cells termed granulomas or tubercles (see Chapters 9 and 12 In the center of such caseous granulomas, accumulated mononuclear cells that mediate the chronic inflammatory reaction to the offending mycobacteria are killed. The necrotic cells fail to retain their cellular outlines but do not disappear by lysis, as in liquefactive necrosis. Rather, the dead cells persist indefinitely as amorphous, coarsely granular, eosinophilic debris. This distinctive type of necrosis is generally attributed to the toxic effects of the mycobacterial cell wall, which contains complex waxes (peptidoglycolipids) that exert potent biologic effects. Photomicrograph of peripancreatic adipose tissue from a patient with acute pancreatitis shows an island of necrotic adipocytes adjacent to an acutely inflamed area. Fatty acids are precipitated as calcium soaps, which accumulate as amorphous, basophilic deposits at the periphery of the irregular island of necrotic adipocytes. The best studied and most clinically important example is ischemic necrosis of cardiac myocytes, the leading cause of death in the Western world. The mechanisms underlying the death of cardiac myocytes are in part unique, but the basic processes that are involved are comparable to those in other organs. Some of the unfolding events may occur simultaneously, whereas others may be sequential. Blood O2, glucose In some instances, necrotic cell death is mediated via signaling cascades. For example, a family of pathogen recognition receptors has been identified that is responsible for recognizing a variety of bacterial and other components. This recognition triggers signaling pathways that can result in damage to mitochondria, lysosomes and cell membranes and are independent of caspase-mediated apoptosis (see below). Pharmacologic interference with several events involved in the pathogenesis of cell necrosis can preserve cell viability after an ischemic insult. Treatments that increase glucose uptake and redress some of the ionic imbalances may preserve myocyte viability during ischemia. It is part of the balance between the life and death of cells and determines that a cell dies when it is no longer useful or when it may be harmful to the larger organism. As a self-defense mechanism, cells that are infected with pathogens or in which genomic alterations have occurred are destroyed. In this context, many pathogens have evolved mechanisms to inactivate key components of the apoptotic signaling cascades. Apoptosis detects and destroys many cells that harbor dangerous mutations, thereby maintaining genetic consistency and preventing the development of cancer. By contrast, as in the case of acquired antibiotic resistance in infectious agents, successful clones of tumor cells often devise mechanisms to circumvent apoptosis. Importantly, individual cells or small groups of cells undergo apoptosis, whereas necrosis characteristically involves larger geographic areas of cell death. Ultrastructural features of apoptotic cells include (1) nuclear condensation and fragmentation, (2) segregation of cytoplasmic organelles into distinct regions, (3) blebs of the plasma membrane and (4) membrane-bound cellular fragments, which often lack nuclei. Cells that have undergone necrotic cell death tend to elicit strong inflammatory responses. By contrast, inflammation is not generally seen in the vicinity of apoptotic cells. Mitochondrial damage promotes the release of cytochrome c (Cyt c) to the cytosol and initiates the apoptotic cascade. A viable leukemic cell (A) contrasts with an apoptotic cell (B) in which the nucleus has undergone condensation and fragmentation. However, most intermediate enzymes that transduce proapoptotic signals belong to a family of cysteine proteases called caspases. In view of the numerous developmental, physiologic and protective functions of apoptosis, the lack of inflammation is clearly beneficial to the organism. These transmembrane proteins have specific amino acid sequences, termed death domains, in their cytoplasmic tails that act as docking sites for complementary death domains of other proteins that participate in the apoptotic signaling process. In turn, caspase-8 stimulates a cascade of other downstream caspases in the apoptosis pathway. Caspase-3 (the most commonly activated effector) in turn activates those enzymes that are responsible for nuclear fragmentation Caspase-3 also destabilizes the cytoskeleton as the cell begins to fragment into apoptotic bodies. Activation of caspase signaling also occurs when killer lymphocytes, mainly cytotoxic T cells, recognize a cell as foreign. Perforin, as its name suggests, punches a hole in the plasma membrane of a target cell, through which granzyme B enters and directly activates procaspase-10 and procaspase-3 Pruning of nonpersistent structures (such as interdigital tissue) during development Removal of self-reactive clones during the generation of immune diversity Removal of senescent cells in organs continuously repopulated from stem cells (such as the gastrointestinal mucosa, epidermis and hematopoietic system) Regression of hyperplasia in organs responding to changing trophic signals This effect can be viewed as a means to eliminate infected cells before they can spread the virus. In some cases, these viral proteins bind and inactivate certain cellular proteins In other instances, they may act at various points in the signaling pathways that activate apoptosis. Apoptosis Comprises Several Signaling Pathways Apoptosis reflects several different pathways that lead to similar end points. Intrinsic Apoptosis and Mitochondrial Proteins Mitochondrial proteins of the Bcl-2 family are keys to the balance between cell life and death and are divided into two groups based on the consequences of their overexpression or preponderance. Heterodimers of proapoptotic and antiapoptotic proteins favor cell survival by sequestering the proapoptotic component. Extrinsic pathway apoptosis reflects the activation of certain membrane receptors by their ligands Intrinsic pathway apoptosis is triggered by diverse intracellular stresses and is characterized by a central role for mitochondria. Procaspase-10 is shown as an example of procaspases that are activated by granzyme B. The equilibrium between proapoptotic and antiapoptotic members of the Bcl-2 family of proteins reflects binding of antiapoptotic members to themselves (homodimers) or to the proapoptotic proteins Bak and Bax. Activation of p53, for example, increases production of proapoptotic members of the Bcl-2 family As a result, these outcompete Bax and Bak by binding to the antiapoptotic components such as Bcl-2 and Bcl-X. The release of Cyt c into the cytosol is a key step in the initiation of intrinsic apoptosis. The complex of Cyt c, Apaf-1 and the now active caspase-9 is sometimes called the apoptosome. The Equilibrium between Proapoptotic and Antiapoptotic Signals Apoptosis can be viewed as a default pathway, and the survival of many cells is contingent upon continued predominance of antiapoptotic (prosurvival) signals. More importantly, Akt activates nuclear factor- B, an important transcription factor that promotes the expression of proteins that prevent the loss of Cyt c from mitochondria, thereby promoting cell survival. At other times, apoptosis is a pathologic process that contributes to many disorders, especially degenerative diseases. Thus, pharmacologic manipulation of apoptosis is an active frontier of drug development. Biologic Aging Biologic aging can be defined as a constellation of deleterious functional and structural changes that are inevitable consequences of longevity. Many human tumors thus display continued expression of telomerase (see Chapter 5). Telomere shortening in blood mononuclear cells has been found to correlate as a marker with the presence of several age-related diseases such as atherosclerosis and Alzheimer disease. However, a simple explanation of the role of replicative senescence in either aging or tumor suppression is unlikely. Although the aging process may increase vulnerability to many diseases, it is independent of the pathogenesis of any specific illness. By contrast, it is estimated that the usual age at death of Neolithic humans was 20 to 25 years, and the average life span today in some regions is often barely 10 years more. Interestingly, the maximum life span attained is not significantly altered by a protected environment. Even if diseases associated with old age, such as cardiovascular disease and cancer, were eliminated, only a modest increase in average life expectancy would be seen. These activities tend to decrease the level of cell activation (increased metabolic rate). Various theories of cellular aging have been proposed, but the evidence adduced for each is at best indirect. Support for the concept of a genetically programmed life span comes from studies of replicating cells in tissue culture. In this context, normal cultured human fibroblasts undergo about 50 population doublings, after which they stop dividing and are irreversibly arrested in the G1 phase of the cell cycle. Moreover, cells from persons afflicted with a syndrome of precocious aging, such as progeria (see below), display a conspicuously reduced number of population doublings in vitro. However, if normal cells in culture are exposed to an oncogenic virus or a chemical carcinogen, they continue to replicate indefinitely. Although immortalization does not necessarily confer tumorigenic capacity, it is a step in that direction (see Chapter 5). The Impact of Oxidative Stress on Aging An important hypothesis holds that the loss of function that is characteristic of aging is caused by progressive and irreversible accrual of molecular oxidative damage. To overcome these end replication limitations, many eukaryotic cells express a ribonucleoprotein enzyme, telomerase, which extends the length of telomeres at the ends of chromosomes and allows continued cell division. Increased Sirt1 activity also promotes survival by increasing Ku70 and thus inhibiting Bax. However, it should be emphasized that a number of studies have been done in many hundreds of thousands of people given antioxidant dietary supplements. These studies have failed to demonstrate any significant impact of antioxidants on human life span, disease development or health. Aging and Stem Cells Most of the physiologic changes associated with aging involve deterioration of the functionality of organs For example, senescent or damaged cardiac myocytes are replaced from resident progenitor cell populations. However, with aging, the ability of these progenitor cells to replenish lost cells is Diseases of Premature Aging In humans, the modest correlation in longevity between related persons, the excellent concordance of life span among identical twins and the presence of heritable disease associated with accelerated aging (progeria) lend credence to the concept that aging is influenced by genetic factors. They are afflicted with demyelinating disorders, leading to very premature development of sensory loss and cataracts, with ensuing frailty and cachexia. At this time, there is little consensus, save that senescence and longevity represent the ultimate expression of the interplay of many mechanisms that are involved in cell injury, repair and death. As Maimonides said in the 12th century, "The same forces that operate in the birth and temporal existence of man also operate in his destruction and death. A 10-year-old girl shows the typical features of premature aging associated with progeria. This abnormal protein accumulates in the nucleus from one cell generation to the next, thereby interfering with the structural integrity and organization of the nucleus. Patients typically die in the fifth decade from either cancer or cardiovascular disease. It is characterized by the elaboration of inflammatory mediators as well as the movement of fluid and leukocytes from the blood into extravascular tissues. Inflammation localizes and eliminates microorganisms, damaged cells and foreign particles, thereby paving the way for a return to normal structure and function. These features correspond to the inflammatory events of vasodilation, edema and tissue damage. A fifth sign, functio laesa (loss of function), was added in the 19th century by Rudolf Virchow, who recognized inflammation as a response to tissue injury. Overview of Inflammation Inflammation is best viewed as an ongoing process that can be divided into phases. Initiation results in a stereotypic, immediate response termed acute inflammation. The acute response is characterized by the rapid flooding of the injured tissue with fluid, coagulation factors, cytokines, chemokines, platelets and inflammatory cells and particularly neutrophils. Amplification depends on the extent of injury and the activation of mediators, such as kinins and complement components. Destruction of the inciting agent by phagocytosis and enzymatic or nonenzymatic processes reduces or eliminates foreign material or infectious organisms. At the same time, damaged tissue components are also removed, paving the way for repair to begin (see Chapter 3). Termination of the inflammatory response is mediated by intrinsic anti-inflammatory mechanisms that limit tissue damage. It allows for either restoration of tissue, with return to normal physiologic function, or repair and the development of a scar in place of normal tissue. Certain types of injury trigger a sustained inflammatory response, which is associated with the inability to clear injured tissue and foreign agents. Such a persistent response (which often has an immune component) is termed chronic inflammation.

Similar mutations may also be present in the germline of persons with hereditary cancer predispositions infection under crown cheap 480 mg trimethoprim otc. In addition antibiotics qid buy generic trimethoprim 480 mg on line, certain areas of the genome are particularly prone to mutations and instability antibiotic walmart trimethoprim 480 mg visa. However virus ntl discount 960 mg trimethoprim otc, on rare occasions bacteria 6 facts trimethoprim 480 mg buy visa, telomerase is activated, thereby maintaining telomere length and resulting in cell immortalization, which (at least experimentally) may lead to malignant transformation. Microsatellites are short sequences of up to six base pairs, which can be repeated as many as 100 times. Such regions are inordinately prone to mutations, including changes in the numbers of repeats. On occasion, however, mutations that escape the repair process in the germline or somatic cells are linked to the development of cancer. Successive mutations in similar genes result in increasingly aberrant clones until a malignant phenotype eventually emerges. In a sense, the emergence of malignancy may be viewed as an evolutionary process, wherein we see only the surviving clone. Growth factors and cytokines p53 Role of Normal Cell Cycle Regulation Protooncogenes Cancer may arise from a loss of the restriction (R) points that regulate the normal cell division cycle because most cancer cells lack R points. Passage through the R point is regulated by cyclins, so named for their regulated expression and degradation during the cell cycle. Cells are stimulated to enter G1 from G0 by growth factors and cytokines via protooncogene activation. A critical juncture in the transition of cells from G1 to S phase is the restriction point (R). Interruption of cell cycle progression during G1 and G2 may lead to apoptosis as a default pathway. Such machinery involves a variety of enzyme families that initially detect and then repair different types of injury. These enzymes also communicate with regulators of cell cycle checkpoints to ensure that resulting mutations are not transmitted to daughter cells (see above). The damaged area is excised and replaced, using the opposite strand as a template. Thus, many mutations in protooncogenes lead to resistance to normal autoinhibitory and regulatory constraints. Activation by Mutation Activating, or gain-of-function, mutations in protooncogenes are usually somatic rather than germline alterations. Germline mutations in protooncogenes, which are known to be important regulators of growth during development, are ordinarily lethal in utero. For example, c-ret is incriminated in the pathogenesis of certain heritable endocrine cancers, and c-met, which encodes the receptor for hepatocyte growth factor, is associated with a hereditary form of renal cancer. The translocation activates the c-abl protooncogene (a nonreceptor protein kinase) by the formation of an aberrant fusion protein. The excessive amount of the normal c-myc product, probably in association with other genetic alterations, promotes the emergence of a dominant clone of B cells, driven relentlessly to proliferate as a monoclonal neoplasm. Although the above malignant conditions are initiated by chromosomal translocations, during the progression of many cancers, multiple chromosomal abnormalities take place (translocations, breaks, aneuploidy, etc. Because the pathogenesis of cancer involves multiple genetic events, genomic instability is essential to the generation of these multiple mutations. If one allele is mutated or missing, loss or mutation of the corresponding normal allele creates homozygosity for the abnormal locus. The transforming genes were discovered to be mutant versions of normal genes involved in growth regulation and were termed protooncogenes. Transforming viral oncogenes were termed v-onc genes, and their cellular counterparts (c-) were individual normal genes Activation by Gene Amplification Chromosomal alterations that result in an increased number of gene copies. For example, the erb B protooncogene is amplified in up to one third of breast and ovarian cancers. Amplification of erb B2 in breast and ovarian cancer may be associated with poor overall survival and decreased time to relapse. The N-myc protooncogene may be amplified up to 700-fold in neuroblastomas and is a marker of advanced disease with a poor prognosis. Activation of myc family protooncogenes by means of gene amplification has also been demonstrated in small cell carcinoma of the lung, Wilms tumor and hepatoblastoma. Mechanisms of Activation of Cellular Oncogenes There are three general mechanisms by which a protooncogene is activated to an oncogene: An activating mutation of a protooncogene leads to the constitutive (dysregulated) production of an abnormal protein. The mutations may involve (1) point mutations, (2) deletions or (3) chromosomal translocations. An increase in the expression of the protooncogene may cause overproduction of a normal gene product. Breaks at the ends of the long arms of chromosomes 9 and 22 allow reciprocal translocations to occur. The c-abl protooncogene on chromosome 9 is translocated to the breakpoint region (bcr) of chromosome 22. Karyotypes of a patient with chronic myelogenous leukemia showing the results of reciprocal translocations between chromosomes 9 and 22. Mechanisms of Oncogene Action Oncogenes can be classified according to the roles of their normal counterparts (protooncogenes) in the biochemical pathways that regulate growth and differentiation. Oncogenes and Growth Factors the binding of soluble extracellular growth factors to their specific surface receptors initiates signaling cascades that eventuate in the entry of a cell into the mitotic cycle. In some instances, a growth factor acts on the same cell that produces it (autocrine stimulation). Other growth factors act on the receptors of neighboring cells (paracrine stimulation). Binding of a ligand to the extracellular domain of its receptor stimulates an intrinsic kinase activity in the cytoplasmic domain of the receptor that phosphorylates tyrosine residues on intracellular signaling molecules. Thus, because growth factor receptors can generate potent mitogenic signals, they harbor a latent oncogenic potential, which when activated, overrides the normal controls of signaling pathways. Under normal circumstances, transient binding of a growth factor to its receptor results in the activation of the cytoplasmic tyrosine kinase domain, after which the receptor reverts to its resting state. Certain mutations of growth factor receptors, including truncation of the extracellular or intracellular domains, point mutations and deletions, result in unrestrained (constitutive) activation of the receptor, independent of ligand binding and promotion of dysregulated growth. Of great importance in human cancers are epigenetic changes that result in increased synthesis of growth factors and their receptors. Ras is an effector molecule in the signal transduction cascade that couples the activation of growth factor receptors to changes in nuclear gene transcription. Oncogenes and Nuclear Regulatory Proteins Several nuclear proteins encoded by protooncogenes are intimately involved in the sequential expression of genes that regulate cellular proliferation and differentiation. In sporadic cases of retinoblastoma, the child begins life with two normal Rb alleles in all somatic cells, but both are inactivated by somatic mutations in the retina. In patients with hereditary retinoblastoma, all somatic cells carry one missing or mutated allele of the Rb gene. Thus, the Rb gene exerts a tumor suppressor function, and the development of hereditary retinoblastoma is associated with two genetic events (Knudson "two-hit" hypothesis). Children who inherit a mutant Rb gene also suffer a 200-fold increased risk of developing mesenchymal tumors in early adult life. More than 20 different cancers have been described, with osteosarcoma being by far the most common. Protooncogenes that operate early in the cell cycle (such as c-myc c-fos and c-jun) render the cells competent to receive the final signals for mitosis and are, therefore, termed competence genes. Competence genes play a role in (1) progression from the G1 to the S phase in the cell cycle, (2) stability of the genome, (3) apoptosis and (4) positive or negative effects on cellular maturation. As discussed above, the translocation characteristic of Burkitt lymphoma constitutively activates c-Myc expression. A second mechanism by which a genetic alteration contributes to carcinogenesis is a mutation that creates a deficiency of a normal gene product (tumor suppressor) that exerts a negative regulatory control of cell growth and thereby suppresses tumor formation ("loss of function mutations"). Such genes encode negative transcriptional regulators of virtually every process in multistep carcinogenesis, from cell division through invasion and metastasis. Because both alleles of tumor suppressor genes must be inactivated to produce the deficit that allows the development of a tumor, the normal suppressor gene is functionally dominant. In this circumstance, the heterozygous state is sufficient to protect against cancer. The p53 Gene Family the p53 tumor suppressor gene is a principal mediator of growth arrest, senescence and apoptosis. The p53 gene is located on the small arm of chromosome 17, and its protein product is present in virtually all normal tissues. In fact, mutations of p53 seem to be the most common genetic change in human cancer. Many human cancers exhibit deletion of both p53 alleles, in which case the cell contains no p53 gene product. By contrast, in some cancers, the malignant cells express one normal p53 allele and one mutant version. In these cases, the mutant p53 the Role of Tumor Suppressor Genes in Carcinogenesis Tumor suppressor genes are incriminated in the pathogenesis of both hereditary and spontaneous cancers in humans. The Rb and p53 gene products serve to restrain cell division in many tissues, and their absence or inactivation is linked to the development of malignant tumors. When a mutant allele inactivates the normal one, the former is said be a dominant negative gene. Because p53 is so important in the life and death of cells, it is understandable that both its activity and protein levels are tightly regulated. Thus, most human cancers display either inactivating mutations of p53 or abnormalities in the proteins that regulate p53 activity. Li-Fraumeni syndrome refers to an inherited predisposition to develop cancers in many organs due to germline mutations of p53. Persons with this condition carry germline mutations in one p53 allele, but their tumors display mutations at both alleles. This situation is similar to that determining inherited retinoblastoma and is another example of the two-hit hypothesis Other Tumor Suppressor Genes the number of genes that display tumor suppressor activity is very large. Germline mutations in these genes create genomic instability in cells of both the breast and ovary. A second somatic mutation in the retina leads to the inactivation of the functioning Rb allele and the subsequent development of a retinoblastoma. In sporadic cases of retinoblastoma, the child is born with two normal Rb alleles. It requires two independent somatic mutations to inactivate Rb gene function and allow the appearance of a neoplastic clone. These include (1) promotion of apoptosis, (2) increased cellular immobilization by adherence to matrix proteins and (3) repression of certain cell activation responses. Most normal human cells do not express telomerase, an enzyme that recognizes the end of a chromosome and adds repetitive sequences to maintain telomere length. The expression of this enzyme actually protects the cancer cell by suppressing the development of further, potentially lethal, chromosomal instability. Thus, telomerase activation permits-but does not directly cause-the emergence of cancer. The level of methylation, both hypomethylation and hypermethylation, is important in carcinogenesis. Hypermethylation: Many cancers are distinguished by differing patterns of hypermethylation of CpG islands (areas rich in base sequences containing cytosines that precede guanines). Hypomethylation: Most cancers exhibit global hypomethylation, when compared to their normal tissue counterparts. This change increases as the malignant process advances from a benign proliferation to a malignant tumor. Histone modifications via methylation, acetylation and other mechanisms influence numerous gene activities Normal colonic mucosa features continuous epithelial renewal, with resulting shortening of telomeres, which leads to uncapping of chromosomal ends. Invasive colon carcinoma Histone acetylation is generally associated with transcriptional activation, whereas deacetylation is associated with transcriptional silencing. The most prominent example of suppression of apoptosis in human cancer is the upregulation of the antiapoptotic protein bcl-2 in B-cell neoplasia. As a result of the antiapoptotic properties of bcl-2, the neoplastic clone accumulates in the affected lymph nodes. Autophagy is a process by which by bulk cell constituents are degraded (see Chapter 1). The expression of certain oncogenes, such as ras, tends to stimulate autophagy, which can lead to cellular senescence or death. Autophagy thus represents an alternative pathway of programmed cell death in preventing cancer. These viruses manifest a pronounced tropism for epithelial tissues, and their full productive life cycle occurs only in squamous cells. E7 binds to Rb, thereby releasing its inhibitory effect on cell cycle progression. Viruses and Human Cancer Despite the existence of viral oncogenes, the number of human cancers definitely associated with viral infections is limited. The localization of Burkitt lymphoma to equatorial Africa is not understood, but it has been suggested that prolonged stimulation of the immune system by endemic malaria may be important. Ultimately, this leads to uncontrolled proliferation of a malignant clone of B lymphocytes. The English physician Sir Percival Pott gets credit for relating cancer of the scrotum in chimney sweeps to a specific chemical exposure, namely soot. Today, we realize that other products of the combustion of organic materials are responsible for a man-made epidemic of lung cancer in cigarette smokers. Since that time, the list of organic and inorganic carcinogens has grown exponentially. Many compounds known to be potent carcinogens are relatively inert in terms of chemical reactivity. The solution to this riddle became apparent in the early 1960s, when it was shown that most, although not all, chemical carcinogens require metabolic activation before they can react with cell constituents.

If the tumour can be found and has not spread antibiotic 3 days uti purchase trimethoprim 960 mg line, then its removal can lead to cure The cortisol excess and associated hypokalaemic alkalosis and diabetes mellitus can be ameliorated by medical therapy (see later) antibiotic resistance from animals to humans trimethoprim 480 mg buy cheap. Treatment of the small-cell tumour itself will also virus making kids sick 960 mg trimethoprim purchase otc, at least initially antibiotics for acne alternatives cheap trimethoprim generic, produce improvement (see Chapter 18 do they give antibiotics for sinus infection order trimethoprim 480 mg fast delivery. Most commonly, metyrapone or ketoconazole has been given, often to lower cortisol concentrations before definitive therapy, or while awaiting benefit from pituitary irradiation. The daily dose has to be determined by measuring either plasma or urinary free cortisol to guide dose titration. Metyrapone Metyrapone inhibits 11- hydroxylase which catalyses the conversion of 11­deoxycortisol to cortisol. Nausea is a common side effect and can be alleviated (if not caused by adrenal insufficiency) by giving the drug with milk. Adverse effects of metyrapone include gastrointestinal disturbances (need to ensure not related to unrecognized hypoadrenalism), hirsutism, acne (due to stimulation of androgenic precursors) and hypertension, hypokalaemia, and oedema (due to accumulation of mineralocorticoid precursors). Importantly when assessing response of cortisol hypersecretion to metyrapone it is best to use a 13. In a recent study there was a significant difference in cortisol concentrations reported in the same sample between the two methods. Several approaches may be used to assess the Trans-sphenoidal microadenomectomy I. The insulin hypoglycaemia test eventually demonstrated the return of a normal stress response. Ketoconazole Ketoconazole (an imidazole previously used as an antifungal agent) blocks a variety of steroidogenic cytochrome P450-dependent enzymes (in both the adrenal gland and gonads), and thus lowers plasma cortisol levels. Its main effect is via inhibiting side-chain cleavage, 17,20-lyase, and 11- hydroxylase enzymes. Normalization of cortisol hypersecretion is seen in between 25 and 93% of cases depending on the study reviewed. Abnormal liver function tests occur in 10 to 15% of patients and a severe idiosyncratic hepatic reaction in 1 in 15 000 exposed individuals. Levoketoconazole (the pure 2 S,4R enantiomer of ketoconazole) is currently undergoing phase 3 studies, and may show a more favourable efficacy, safety, and tolerability profile. Mitotane Mitotane is an adrenolytic drug that is taken up by both normal and malignant adrenal tissue, causing adrenal atrophy and necrosis. Because of its toxicity, it has been used mainly in the management of adrenal carcinoma. The drug will also produce mineralocorticoid deficiency, and both glucocorticoid and mineralocorticoid replacement therapy may be required. Importantly, mitotane increases the levels of cortisolbinding globulin within serum and also increases the metabolism of cortisol in the liver and therefore higher doses of glucocorticoid replacement Mitotane can cause several biochemical and endocrine abnormalities, including thyroid dysfunction (a mixed picture of primary and secondary thyroid dysfunction) that may require replacement. Abnormalities in liver function, in particular raised -glutamyl transferase and hyperlipidaemia, are frequently seen. Clinical side effects are common and include fatigue, skin rashes, and gastrointestinal disturbance. Levels of mitotane need to be closely monitored as the drug has a narrow therapeutic window in the treatment of adrenocortical carcinoma. Mitotane toxicity is associated predominantly with gastrointestinal and neurological symptoms, which are reversible on discontinuation of the drug. Mitotane doses at levels below the therapeutic window may be beneficial in controlling hypercortisolaemia, but will not have an impact on growth of adrenocortical cancers. Assessment of disease control in patients on mifepristone include clinical measures such as improvement in hypertension, hyperglycaemia, weight, quality of life, clinical appearance, and symptoms. As it is difficult to assess efficacy, it is generally recommended to start at a low dose of 300 mg per day and titrate up as clinically indicated (max dose of 1200 mg/day). Adverse effects include those associated with adrenal insufficiency (fatigue, nausea, vomiting, arthralgias and headache), antiprogestin (endometrial thickening) and mineralocorticoid excess (hypertension, oedema, hypokalaemia). Given the blockade of the glucocorticoid receptor, treatment of adrenal crisis can be challenging; mifepristone should be held, haemodynamic support given, and one study reported the use of high-dose dexamethasone. It is an imidazole derivative (similar to ketoconazole) which can be given at subhypnotic doses to rapidly decrease cortisol levels by inhibiting side-chain cleavage, 17,20lyase and 11- hydroxylase enzymes. Etomidate should only be given under careful monitoring conditions such as is possible in an intensive care unit because of its potential hypnotic properties. During treatment, cortisol should be measured 4­6 hourly and the etomidate infusion titrated to achieve a serum cortisol level between 280 and 560 nmol/litre (10­20 µg/dl). Cabergoline Cabergoline is a long acting agonist of the D2 dopamine receptor (which is frequently expressed on corticotroph adenomas). Cabergoline is also under investigation in combination with some of the other agents discussed. Primary hypoadrenalism Congenital adrenal hyperplasia Various inherited enzyme defects have been identified in the synthetic pathway of adrenocortical hormones, which cause a spectrum of glucocorticoid and/or mineralocorticoid deficiency. Adrenal androgens may be increased or decreased, depending upon the underlying enzyme block. Addison worked with Bateman, a dermatologist who produced one of the first classifications of skin disease. Leading causes include tuberculosis, fungal infections (histoplasmosis, cryptococcosis), and cytomegalovirus. Pathologically, the adrenal glands are atrophic, with loss of most of the cortical cells, but the adrenal medulla is usually intact. However, catecholamine synthesis may be impaired due the need for intra-adrenal cortisol to regulate catecholamine synthesis (norepinephrine to epinephrine by phenylethanolamine N-methyltransferase). Adrenal autoantibodies can be detected in up to 75% of newly diagnosed cases and have helped elucidate the cause of the disease. The condition is rare and usually presents in childhood with either candidiasis or hypoparathyroidism. Other autoimmune conditions, such as pernicious anaemia, thyroid disease, chronic active hepatitis, and gonadal failure may occur, but are rare. Autoantibodies to the cholesterol side-chain cleavage enzyme and 17-hydroxylase may be detected, but not to 21-hydroxylase. Autoantibodies to 21-hydroxylase are usually present and are predictive for the development of adrenal destruction. Adrenal metastases (most commonly from primary lung and breast tumours) are often found at post-mortem examinations, but adrenal insufficiency from these is uncommon (unless associated with adrenal haemorrhage). Necrosis of the adrenals following intra-adrenal haemorrhage should be considered in any severely ill patient, and may result from infection, trauma, or hypercoagulability. Intra-adrenal bleeding may be found in severe septicaemia of any cause, particularly in children. When this is caused by meningococci, the association with adrenal insufficiency is known as Waterhouse­Friderichsen syndrome. Adrenal infiltration/ replacement leading to glandular failure may also occur with amyloidosis and haemochromatosis. Congenital adrenal hypoplasia is an X-linked disorder comprising congenital adrenal insufficiency and hypogonadotropic hypogonadism. X-linked adrenoleukodystrophy causes adrenal insufficiency in association with demyelination within the nervous system, and results from a failure of -oxidation of fatty acids within peroxisomes. Male patients have the fully expressed condition, and female carriers are increasingly recognized to be affected by it (albeit with different timings of symptom development). Adrenal insufficiency is usually present, but does not appear to correlate with the neurological deficit. Bone marrow transplantation appears to be more effective if undertaken in the early stages of the disease. Such therapy suppresses the hypothalamic­pituitary­adrenal axis, with consequent adrenal atrophy that may last for months to years after stopping glucocorticoid treatment. Adrenal atrophy and subsequent deficiency should be anticipated in any subject who has taken more than the equivalent of 30 mg of oral hydrocortisone per day (approximately 7. Hypoadrenalism may also complicate critical illness, even in individuals with a previously intact hypothalamic­pituitary­adrenal axis. This functional adrenal insufficiency is usually transient and not caused by a structural lesion. This is a controversial area and debate continues regarding its diagnosis, aetiology, and treatment. This is beyond the scope of this chapter (for further information, see suggested reading). Clinical features the most obvious feature differentiating primary from secondary hypoadrenalism is skin pigmentation. The pigmentation is seen in sun-exposed areas, recent rather than old scars, axillae, nipples, palmar creases, pressure points, and in mucous membranes (buccal, vaginal, vulval, anal). Patients with primary adrenal failure usually have both glucocorticoid and mineralocorticoid deficiency. By contrast, those with secondary adrenal insufficiency have an intact renin­angiotensin­ aldosterone system. This accounts for differences in salt and water balance in the two groups of patients, which in turn result in different clinical presentations. Primary adrenal failure may present with hypotension and acute circulatory failure (Addisonian crisis). Anorexia may be an early feature that progresses to nausea, vomiting, diarrhoea, and sometimes, abdominal pain. These crises may be precipitated by intercurrent infection or by stress, such as surgery. Alternatively, the patient may present with vague features of chronic adrenal insufficiency-weakness, tiredness, weight loss, nausea, intermittent vomiting, abdominal pain, diarrhoea or constipation, general malaise, muscle cramps, and symptoms suggestive of postural hypotension. The lying blood pressure is usually normal, but almost invariably there is a fall in blood pressure on standing. Mineralocorticoid status In primary hypoadrenalism there is usually mineralocorticoid deficiency, with elevated plasma renin activity or concentration and either low or low-normal plasma aldosterone. Plasma cortisol levels are measured at 0 and 30 min after tetracosactide administration, and a normal response is defined by a peak plasma cortisol of more than 450­500 nmol/litre (the exact threshold is assay dependent). Levels less than this in response to tetracosactide are found in both primary and secondary adrenal insufficiency. False-positive results have occasionally been reported, particularly in cases of suddenonset secondary hypoadrenalism. Investigation Routine biochemical profile In established primary adrenal insufficiency, hyponatraemia is present in about 90% of cases and hyperkalaemia in 65%. In secondary adrenal failure there may be dilutional hyponatraemia, with normal or low blood urea, because glucocorticoids are required to maintain the glomerular filtration rate and excrete a water load. Hypoglycaemia has been found in up to 50% of patients with chronic adrenal insufficiency. Basal plasma cortisol concentrations are often in the low normal range and cannot be used to exclude the 13. Children, hydrocortisone 50­100 mg/m2 bolus followed by hydrocortisone 50­100 mg/m2/d divided q 6 h For hypoglycaemia: dextrose 0. Alternatively, 5­10 ml/kg of D10W for children <12 years old Cardiac monitoring: rapid tapering and switch to oral regimen depending on clinical state Acute adrenal crisis Abbreviation: D10W, 10 % dextrose solution; D25W, 25% dextrose solution. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. Other tests Radioimmunoassays to detect autoantibodies, such as those against the 21-hydroxylase antigen, are available and should be undertaken in patients with primary adrenal failure. Once the patient has been stabilized, the patient can have a Synacthen test (with omission of evening and morning dose of hydrocortisone prior to test; once the test is complete the patient can receive their usual morning dose of hydrocortisone). In the acute setting, patients should be treated in a critical care setting and intravenous hydrocortisone should be given immediately at a dose of 100 mg, followed by 200 mg of hydrocortisone per 24 hours (either as a continuous infusion or 50 mg by injection every 6 hours). Clinical improvement, especially in blood pressure, should be seen within 4 to 6 h if the diagnosis is correct. It is important to recognize and treat any associated condition, such as an infection that may have precipitated the acute adrenal crisis. If the patient continues to recover and the precipitant has been treated then, if the patient can take by mouth, hydrocortisone can be switched to the oral route, 40 mg in the morning and 20 mg at 18. Some patients will require more than 30 mg/day, but most patients require less than this (usually 15­25 mg/day). Chronic adrenal insufficiency Glucocorticoid replacement Long-term treatment requires glucocorticoid replacement; doses vary between 15 and 25 mg hydrocortisone (or 20­35 mg cortisone acetate) in divided doses (either twice or thrice daily), with the largest dose on waking to mimic the circadian rhythm. Hydrocortisone is to be doubled or trebled in the event of intercurrent stress or illness. Higher doses may be required in some patients but there needs to be caution in using higher doses for prolonged periods due to the potential of chronic glucocorticoid overexposure. Monitoring of glucocorticoid replacement should be performed by clinical assessment including body weight, postural blood pressure, energy levels, and signs of frank glucocorticoid excess. A newly marketed modified release hydrocortisone preparation can be administered once/ twice daily and other slow release preparations are in development. Patients receiving glucocorticoid replacement therapy should be advised to double/treble the dose in the event of an intercurrent febrile illness, accident, or in some cases of psychological stress. If the patient is vomiting and cannot take by mouth, parenteral hydrocortisone must be given urgently, as indicated earlier. For minor surgery, 50 to 100 mg of hydrocortisone is given with the premedication. For major procedures this is then followed by the same regimen as for acute adrenal insufficiency.

If the patient is in steady state antibiotics used to treat mrsa generic trimethoprim 480 mg fast delivery, this will both maintain satisfactory glycaemic control and prevent hypokalaemia (insulin enhances potassium entry into skeletal muscle) infection walking dead 480 mg trimethoprim with visa. This regimen should be started on the morning of surgery and continued until the patient is able to eat and drink normally bacteria joint pain 480 mg trimethoprim purchase otc, when the usual treatment can be resumed antibiotic questions trimethoprim 960 mg purchase free shipping. Adjustments to the insulin infusion rate are made aiming to keep blood sugars between 6 and 10 mmol/litre (acceptable levels 4­12 mmol/litre) bundespolizei virus trimethoprim 480 mg buy with amex. When using a variable-rate intravenous insulin infusion the capillary glucose should be checked hourly and the serum electrolytes measured daily. Acute metabolic complications of diabetes and their treatment Diabetic ketoacidosis this is uncontrolled hyperglycaemia with hyperketonaemia severe enough to cause metabolic acidosis. It remains a major cause of death in patients with type 1 diabetes under 20 years of age, although the mortality has fallen from 8% to 0. Causes Diabetic ketoacidosis only develops when severe insulin deficiency, compounded by an excess of glucagon, stimulates lipolysis and a massive increase in ketogenesis (see earlier). However, diabetic ketoacidosis can occur in subjects with type 2 diabetes who are relatively insulin deficient, especially when the secretion of counterregulatory hormones (especially glucagon) is increased by severe intercurrent illness. Precipitating factors include: · newly presenting type 1 diabetes · omission or underdosing of insulin by established type 1 diabetic patients, which may be deliberate in patients with disturbances of body image · intercurrent illness, such as infections, myocardial infarction, stroke, trauma, surgery, and burns; many patients (and their doctors) fail to increase insulin dosages or monitor blood glucose during such events About 30 to 40% of episodes are unexplained; omitted or inadequate insulin treatment should always be suspected if no obvious infective or other cause is found. Pathophysiology Diabetic ketoacidosis is due to the accumulation of ketones, that is, acetoacetate and its derivatives, 3-hydroxybutyrate (or -hydroxybutyrate) and acetone They are generated by -oxidation of free fatty acids within the mitochondria of the liver. Free fatty acids enter the cytoplasm of hepatocytes and combine with coenzyme A (CoA) to form their fatty acyl-CoA derivatives. The latter is converted to acetoacetate, which may be oxidized to 3-hydroxybutyrate or undergo condensation to produce acetone. Ketones are transported out of the liver and are used as metabolic fuels by various tissues including the brain; they supply a few% of total energy needs after an overnight fast, but the proportion rises to over one-third during prolonged fasting. When produced in excess, they can accumulate rapidly, especially if plasma levels exceed 5 mmol/litre (about 10 times normal), when tissue uptake mechanisms become saturated. Ion exchange across cell membranes leads to intracellular acidosis which compromises cellular metabolism because many crucial enzymes operate within a narrow pH range. Clinical measurements of acidbase status are confined to the extracellular fluid and may underestimate the severity of intracellular acidosis. They therefore exacerbate the osmotic diuresis caused by glycosuria and the resulting polyuria, electrolyte losses, dehydration, and hypovolaemia. Clinical features Diabetic ketoacidosis usually presents with classical hyperglycaemic symptoms (see Table 13. The patient generally looks ill and may show postural hypotension and other signs of dehydration and hypovolaemia. Some patients are hypothermic due to heat loss from peripheral vasodilation, and this may mask the pyrexia of infection. Children with diabetic ketoacidosis often complain of abdominal pain, sometimes mimicking acute appendicitis or other surgical emergencies. Investigations and diagnosis Once suspected, the diagnosis can be confirmed on the spot with a finger-prick blood glucose measurement and urine or blood analysis for ketones. Recent guidelines place emphasis on the value of bedside finger-prick testing for blood ketones both in diagnosis (plasma ketone level >3. Treatment with intravenous saline and insulin should begin immediately, and baseline investigations Insulin deficiency + glucagon excess Blood ketones Blood glucose Vomiting Osmotic diuresis Acidosis Cellular dysfunction induced by intracellular acidosis, as well as cerebral oedema and shock are potentially life-threatening. For those who are not shocked give: · 1 to 2 litres in 2 h, then · 1 litre over the next 4 h, then · 4 litres over the next 24 h Fluid losses in urine or vomit should be added to these volumes. Shocked or oliguric patients may require faster fluid repletion, possibly with plasma expanders rather than saline, while slower replacement is safer in those with signs of fluid overload, myocardial infarction, heart failure, or any suspicion of cerebral oedema. Urine output must be monitored closely, as must blood pressure, central venous filling, and signs of pulmonary or peripheral oedema. Saline containing potassium is the logical fluid to replace the losses of Na+, K+, and Cl­ induced by the osmotic diuresis of diabetic ketoacidosis. The use of intravenous bicarbonate to try to correct acidosis is contentious, both in terms of biochemistry and clinical outcome (see next). It is now recommended that 10% dextrose is added (125 ml/h) as an additional infusion alongside the rehydration with saline when plasma glucose has fallen to below 14 mmol/litre to prevent hypoglycaemia (insulin is still required to prevent ketogenesis and promote glucose utilization in the tissues). Paradoxically, therefore, intravenous bicarbonate administration could worsen intracellular acidosis and there is evidence from animal models of acidosis that this occurs. Worryingly, a recent study identified bicarbonate administration as the most important independent predictor of cerebral oedema in children with moderately severe diabetic ketoacidosis. Venous blood is taken for biochemical screening and can also be used to assess acid-base status as the difference between arterial and venous pH is 0. Typical values and some diagnostic pitfalls in diabetic ketoacidosis are shown in. Management Diabetic ketoacidosis is a potentially life-threatening medical emergency that requires urgent treatment with scrupulous clinical and biochemical monitoring: many avoidable and serious accidents still happen because the patient is abandoned once treatment has been started. Severe diabetic ketoacidosis is best managed initially on a high-dependency or intensive care unit. The highest priority is to correct hypovolaemia and dehydration, which will often improve acidosis and hyperglycaemia. However, it now appears likely that the high mortality of diabetic ketoacidosis has been partly due to overenergetic replacement of intravenous fluids (especially bicarbonate) and perhaps insulin, which may predispose to the development of cerebral oedema. Fluid replacement Good intravenous access is crucial: a large peripheral vein may be used but a central venous cannula is safest for severely hypovolaemic patients and for older people or those at risk of heart failure, in whom monitoring of central venous pressure is essential. Plasma K+ levels can therefore be low, normal, or high, and dangerous hyperkalaemia can be present, especially if severe hypovolaemia causes prerenal failure. During insulin replacement, K+ is carried intracellularly with glucose, and plasma K+ levels can fall rapidly. Insulin replacement Continuous fixed rate intravenous infusion is the best way to give insulin in diabetic ketoacidosis; subcutaneous and intramuscular absorption are too erratic to be safe and the rate of fall of glucose (one of the factors implicated in cerebral oedema) cannot be easily controlled. Because the half-life of insulin in the circulation is only a few minutes, blood glucose and ketone levels will rise rapidly if insulin delivery is interrupted; hourly monitoring of blood glucose is therefore mandatory during intravenous insulin. Failure of glucose to fall usually means that the pump has been turned off or that the infusion cannula is blocked. When blood glucose falls to below 14 mmol/ litre an infusion of 10% dextrose 1 litre per 8 hours is then recommended, along with any saline rehydration, to prevent hypoglycaemia and to allow the same rate of insulin infusion to correct the ketosis. If these parameters are not being met the infusion system should be carefully checked and, if working properly, increases in the fixed rate insulin infusion by 1 U/h are made until an adequate response is achieved. Resolution of ketosis is said to have occurred when the following criteria are satisfied: plasma ketones less than 0. The urine may misleadingly still test positively for ketones at this stage due to excretion of the previous ketone load. Once resolution of ketosis is confirmed, the patient can be converted back to their usual subcutaneous insulin regimen (or begun on a regimen if this is a new diagnosis of diabetes), assuming they are able to eat and drink normally. If it is impossible to give a controlled intravenous infusion, then intramuscular soluble insulin can be injected every 4 h or so, starting with 20 U and attempting to titrate subsequent dosages Myocardial infarction (see next) has a poor prognosis if it causes diabetic ketoacidosis. Plasma expanders and inotropes may occasionally be required for severe hypotension, although rehydration, as already mentioned, is usually adequate. Cerebral oedema still accounts for 50% of fatalities in diabetic ketoacidosis, especially in children, although modern management protocols with slower fluid replacement and low-dose intravenous insulin infusion can markedly reduce its incidence. The cause is thought to be shifts of ions and water into the brain, particularly the movement of water into dehydrated, hypertonic cells when relatively hypotonic fluids reach the extracellular space. Such shifts would be predicted with the administration of isotonic and particularly with hypotonic fluids. Risk factors for cerebral oedema include overrapid falls in blood glucose, excessive fluid replacement, and high insulin dosages. Insulin can affect various ion transport mechanisms in the brain, but its role remains mysterious and may simply reflect changes in extracellular osmolarity. Swelling of the brain within the cranium causes coning, leading to cardiorespiratory arrest. Adult respiratory distress syndrome is due to accumulation of fluid in the alveoli, perhaps due to ionic and water shifts or to excessive leakiness of the pulmonary capillaries. Hypoxia is severe, and chest radiography shows an appearance like left ventricular failure but with a normal heart size. It carries a poor prognosis, but ventilation with highconcentration oxygen may be useful supportive treatment. Acute gastric dilatation (gastroparesis) presents with vomiting and may produce a succussion splash and a ground-glass appearance on abdominal radiograph. Nasogastric drainage may be needed to prevent aspiration, especially in the unconscious patient. Hypotension may persist or develop during treatment and generally reflects inadequate fluid replacement. Alternative causes of hypotension including septic shock and cardiogenic shock should also be considered. Persisting acidosis despite correction of blood sugar levels and a fall in plasma (and later urine) ketones raises the possibility of lactic acidosis secondary to sepsis or metformin use (see next). Plasma sodium levels may rise despite fluid replacement as the initial high glucose levels may have resulted in an erroneously low initial reading. Falling sodium levels may reflect the need for more saline and less dextrose-based fluid replacement. Subsequent management When the patient can eat and drink, intravenous fluids and insulin can be discontinued. There is no need for an insulin infusion; instead, the patient can be restarted on their usual subcutaneous insulin regimen (or a new regimen, if newly diagnosed). The intravenous insulin infusion should be maintained until the first injection containing soluble or short-acting analogue insulin has had time to act (the intravenous infusion should not be stopped if only basal insulin has been given). The causes of the episode must be determined if possible, and efforts made to prevent a recurrence. Recurrent diabetic ketoacidosis is a feature of brittle diabetes, and these patients need careful monitoring and counselling. Ketosis does not develop because circulating insulin levels are high enough to suppress lipolysis and ketogenesis; these patients are therefore C-peptide positive, with type 2 diabetes which is often previously undiagnosed. Precipitating factors include myocardial infarction, stroke, infection, and diabetogenic drugs such as glucocorticoids and thiazide diuretics; fizzy glucose drinks may also contribute. Presentation is typically with classical hyperglycaemic symptoms (polyuria, intense thirst, weight loss, blurred vision), without the features of ketoacidosis. At blood glucose levels over 30 mmol/litre, drowsiness can lead to a cycle of deterioration as fluid loss continues due to the osmotic diuresis, but the patient is increasingly too lethargic to drink adequate replacement fluids. Progressive dehydration then leads to even higher glucose levels, more lethargy, and a further decline in oral intake. Complications include thrombotic events such as stroke and peripheral arterial occlusion, and deep venous thrombosis and pulmonary embolism, these being due apparently to increased blood viscosity. Mortality is 15 to 20%, partly because these patients are old and often have a serious precipitating illness. Rehydration will lower the blood glucose level, which will lower osmolality and fluid will shift into the intracellular space. The falling glucose will cause a rise in sodium levels which is not an indication for hypotonic saline; a rising sodium is only cause for concern if the osmolality is not falling. A safe glucose fall is by 4 to 6 mmol/l per hour, aiming for a glucose of 10­15 mmol/litre. If significant ketones are present intravenous insulin should be started immediately however if not insulin should not be commenced immediately as it may drop osmolality dramatically and precipitate cardiovascular collapse. Once rehydration is adequate and glucose is still not falling then intravenous insulin may be started at a rate of 0. Hyperglycaemia can be greater than in diabetic ketoacidosis (typically >30 mmol/litre) and, together with a rise in urea due to dehydration and prerenal failure, may elevate the plasma osmolality to well over 350 mosmol/kg (usually >320 mosmol/kg). Intercurrent illness, such as infection, must be sought and treated appropriately. After recovery, many of these patients should be converted to insulin however after weeks to months can be successfully weaned off insulin. Falling glucose levels are sensed by glucose-sensitive neurons, which are found in the periphery (vagal sensory endings in the portal vein) and medulla as well as the hypothalamus. Features include pallor (cutaneous vasoconstriction), sweating (which can be very profuse), tremor (a 2-adrenergic effect on skeletal muscle), and tachycardia; systolic blood pressure rises due to increased cardiac output while pulse pressure widens-giving the typical bounding pulse-because 2-mediated vasodilatation in skeletal muscle causes peripheral resistance to fall. Hypoglycaemia also triggers the secretion of counterregulatory hormones, namely glucagon and adrenaline (both crucial to restoring euglycaemia), growth hormone, and cortisol. Collectively, these inhibit insulin secretion and raise blood glucose by enhancing hepatic glycogenolysis and gluconeogenesis, causing glucose to pour out of the liver. Defects in glucagon or adrenaline release (which occur in long-standing type 1 diabetes, for example), or in the ability of the liver to produce glucose The physiological and neurological features of hypoglycaemia usually develop in a fixed sequence when blood glucose is lowered in a controlled fashion in the laboratory. However, this hierarchy may not be apparent in real life, and some patients specifically lose their awareness of the early warning symptoms (see next). Lactic acidosis is best known in diabetic patients as a rare but often fatal complication of the biguanides, phenformin and metformin, which act mainly by inhibiting hepatic gluconeogenesis. The risk is about 10 times higher with phenformin than with metformin, and it is very rare during metformin treatment as long as other predisposing factors (the major organ failures) are avoided. Lactic acidosis presents as coma with metabolic acidosis (reduced arterial pH and venous bicarbonate) and a wide anion gap due to hyperlactataemia. Intravenous sodium bicarbonate may paradoxically aggravate intracellular acidosis, although forced ventilation to blow off carbon dioxide may help (see earlier). Haemodialysis may both clear lactate and hydrogen ions, and correct any sodium overload following bicarbonate administration. Sodium dichloroacetate, which stimulates pyruvate dehydrogenase to metabolize lactate, is undergoing evaluation. Mortality remains high (>30%), partly because of the organ failures that commonly coexist. Hypoglycaemia Hypoglycaemia is an inevitable side effect of antidiabetic drugs that raise circulating insulin levels, namely insulin itself and sulphonylureas; it does not occur with metformin or thiazolidinediones alone, or with dietary restriction.

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop antimicrobial garlic trimethoprim 960 mg buy visa. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop antibiotic joint spacer 960 mg trimethoprim purchase with mastercard. The patient has a normal right hand virus 888 discount trimethoprim 480 mg buy online, but there is shortening of the left fourth metacarpal (brachydactyly) virus notification order generic trimethoprim online. In addition to brachydactyly safe antibiotics for sinus infection while pregnant trimethoprim 960 mg order with visa, other skeletal abnormalities of the long bones and shortening of the metatarsals may also occur. Moreover, in affected individuals the deletion involved the maternal allele, whereas its occurrence on the paternal allele resulted in unaffected healthy 13. Adrenocortical diseases are relatively uncommon, but they have detrimental clinical consequences and can be treated effectively. The commonest cause of secondary hypoadrenalism is stopping of exogenous glucocorticoid therapy or its inadequacy in stressful situations. Clinical features-primary adrenal failure may present (1) acutely- with hypotension and acute circulatory failure (Addisonian crisis); or (2) chronically-with vague features of ill health, sometimes including gastrointestinal symptoms, features suggestive of postural hypotension, and salt craving. Skin pigmentation is nearly always present in primary adrenal insufficiency (but not in secondary). Management-patients presenting acutely should be treated in a critical care setting with immediate intravenous hydrocortisone (100 mg, followed by 200 mg per 24 h). Appropriate fluid replacement and glucose/ electrolyte monitoring and treatment are also central to effective management, along with treatment of any precipitating condition. Long-term treatment requires glucocorticoid replacement in divided doses, with the largest dose on waking to mimic the circadian rhythm, and with the dose typically doubled in the event of intercurrent stress or illness. Patients should be supplied with, and trained in how to use, an emergency hydrocortisone injection. The diagnosis is often challenging, but in the absence of confounding influences is suggested by a high random plasma aldosterone/renin ratio, especially if plasma aldosterone concentration is over 415 pmol/litre (15 ng/dl). Adrenal vein cannulation with sampling for estimation of aldosterone/cortisol ratio may be required to ensure appropriate lateralization. Treatment of a unilateral adrenal adenoma is by surgical excision and of bilateral adrenal hyperplasia is medical, usually with spironolactone. Several single gene defects can cause mineralocorticoid excess, including 17-hydroxylase deficiency, 11-hydroxylase deficiency, glucocorticoid- suppressible hyperaldosteronism, and apparent mineralocorticoid excess (mutations in 11-hydroxysteroid dehydrogenase type 2 gene). Mineralocorticoid deficiency this is most commonly seen in the context of primary hypoadrenalism but is also caused (rarely) by conditions including primary defects in aldosterone biosynthesis, defects in aldosterone action, and hyporeninaemic hypoaldosteronism (most commonly in the context of diabetic nephropathy or chronic interstitial nephritis). Introduction An initial rate-limiting step in adrenal steroidogenesis is the uptake of cholesterol from circulating cholesterol bound to low-density lipoprotein, by mitochondria in the adrenal cortex. Aldosterone acts physiologically to stimulate sodium transport across epithelial cells in the distal nephron, colon, and salivary gland. The mineralocorticoid receptor, however, is nonselective in vitro; paradoxically, cortisol and aldosterone have the same intrinsic affinity for the mineralocorticoid receptor, raising the question of why aldosterone is the preferred mineralocorticoid in vivo. Glucocorticoids have more diverse and extensive roles than mineralocorticoids, regulating sodium and water homeostasis, glucose and carbohydrate metabolism, inflammation, and stress. Adrenocortical diseases are most readily classified by whether they are characterized by hormone excess or deficiency (Table 13. The adrenal glands show bilateral adrenocortical hyperplasia, with widening of the zona fasciculata and zona reticularis. Long-term prescription rates for oral glucocorticoids have increased in recent decades, as has the use of inhaled, intranasal, and topical glucocorticoid therapy. In patients who received oral or intravenous steroids the rate of failure on Synacthen testing was 44. Indeed, studies have shown that patients who receive exogenous glucocorticoids at doses 7. If these patients have their steroids stopped abruptly, or if they are unwell and do not follow directions for stress dose steroids, they may develop an adrenal crisis. As such, if these patients are discontinuing their exogenous glucocorticoid therapy, they may require replacement doses of glucocorticoids until their hypothalamic­pituitary­adrenal axis recovers. Cushing himself raised the question of whether his disease was a primary pituitary condition or secondary to an abnormality of the hypothalamus. There is abundant evidence to indicate that the condition is related to the pituitary rather than the hypothalamus. In over 90% of cases it is caused by a pituitary adenoma of monoclonal origin; basophilic hyperplasia is very rare, and selective surgical removal of the microadenoma usually results in remission. It is characterized by pigmented lesions of the skin and mucosae, cardiac, cutaneous, and other myxomatous tumours, and multiple other endocrine (pituitary, adrenal, thyroid, gonads) and nonendocrine neoplasms (eye, breast, uterus, liver, bone). The biochemical clues were the presence of subnormal morning levels of plasma cortisol and a rise in cortisol after food. Not surprisingly, the clinical syndrome is related to food intake; fasting can produce adrenal insufficiency. More recently, several novel mechanisms which regulate cortisol secretion from adrenal nodules have been uncovered. The frequency and pathogenesis of this condition remain unknown, but a two-hit hypothesis has been put forward to explain its aetiology. Chronic liver disease, irrespective of the cause, is associated with impaired cortisol metabolism, but in those consuming excess alcohol this is associated with an increase in the cortisol secretion rate, rather than concomitant suppression in the face of impaired metabolism. With abstinence from alcohol the biochemical abnormalities rapidly revert to normal. Gonadal dysfunction is very common, with menstrual irregularity in females and loss of libido in males, resulting from a suppressive effect of cortisol on gonadotropin secretion. Depression and lethargy are among the most common problems, but poor concentration, paranoia, and overt psychosis are also well recognized. Lowering of plasma cortisol by medical or surgical therapy usually results in a rapid improvement in the psychiatric state. Pathological fractures, either spontaneous or after minor trauma, are not uncommon. The radiographic appearance is typical, with exuberant callus formation at the site of the healing fracture. The typical red-purple livid striae of the syndrome are found most frequently on the abdomen, but may also be present on the upper thighs and axilla. They are very common in younger patients, and less so in those over 50 years of age. Complaints of weakness, such as an inability to climb stairs or get up from a deep chair, are relatively uncommon, but observation of whether the patient can rise from a crouching position often reveals the problem. In many instances these are asymptomatic, as the normal inflammatory response may be suppressed. Glucose intolerance may be a predisposing factor, with overt diabetes being present in up to onethird of patients in some series. Cataracts, a well-recognized complication of exogenous corticosteroid therapy, seem to be uncommon, except as a complication of diabetes. The result of the aforementioned abnormalities is a reduction of activated partial thromboplastin time and increased thrombin generation. Therefore, these patients are at high risk of thromboembolic disease and should be treated with prophylactic anticoagulation in keeping with guidance for highrisk patients. Establishing a diagnosis and cause can be difficult; normal pregnancy is associated with a threefold increase in plasma cortisol caused by increased production rates and increases in cortisol-binding globulin. Urinary free cortisol also rises, and dexamethasone does not suppress plasma cortisol to the same degree as in the nonpregnant state. However, salivary cortisol levels/ profiles are potentially helpful (as they reflect unbound free cortisol levels). Adrenal and/or pituitary adenomas should be excised (most frequently performed in the second trimester). Adrenocortical carcinomas In addition to features of glucocorticoid excess the patient may present with other problems relating to: (1), the tumour Thus, in addition to hirsutism, there may be other features of virilization in females, including clitoromegaly, breast atrophy, deepening of the voice, temporal recession, and severe acne. Accurate diagnosis can be challenging as no single test confers 100% sensitivity and specificity. Depending on the index of clinical suspicion these can be performed in isolation or combination. The length of each cycle, and the intervening period between episodes, can vary markedly from days to months and even years. Most patients have been thought to have pituitary-dependent disease, and in many instances, basophil adenomas have been removed, some with long-term cure. Children All the aforementioned features occur in children, but growth arrest is almost invariable. In addition to glucocorticoid-induced growth arrest, androgen excess may result in precocious puberty. However, several cases have been reported, 50% of which resulted from adrenal adenomas. Various doses of dexamethasone have been used, usually given at 23:00 h, but most experience is with a dose of 1 mg. Thus, the outpatient 1 mg dexamethasone suppression test has high sensitivity but low specificity, and further investigation is often required. This test is reported as having a sensitivity of 96% and a specificity of between 70 and 80%. Drugs which accelerate dexamethasone metabolism include phenobarbital, phenytoin, carbamazepine, primidone, rifampicin, rifapentine, ethosuximide, pioglitazone. Drugs which impair dexamethasone metabolism include itraconazole, ritonavir, fluoxetine, diltiazem, cimetidine, and aprepitant/fosaprepitant. Healthy women who receive oral oestrogen therapy will often fail the dexamethasone suppression test (50% false-positive rate) due to elevated levels of cortisol-binding globulin. However, the sensitivity and specificity of these methods is poor, and these assays have now been replaced with the much more sensitive measurement of urinary free cortisol excretion. As cortisol secretion increases, the binding capacity of cortisol-binding globulin is exceeded, resulting in a disproportionate rise in urinary free cortisol. However, this test has largely been replaced by midnight salivary cortisol for this indication. Random morning levels of plasma cortisol are therefore of little value in making the diagnosis. In addition, various factors, such as the stress of venepuncture, intercurrent illness, and admission to hospital, may result in normal subjects losing their circadian rhythm. It is therefore good practice not to measure plasma cortisol until the patient has been in hospital for 48 hours. For practical reasons midnight plasma cortisol is not routinely used as a first-line screening test. By contrast, midnight salivary cortisol can be collected at home and offers greater accuracy. The most commonly accepted salivary cortisol cut-off is less than 4 nmol/litre at midnight. Other screening and confirmatory tests may be required to evaluate false-positive results. The original test introduced by Liddle was based on giving dexamethasone at a dose of 2 mg every 6 h for 48 h and measuring urinary 17-oxogenic steroids. Suppression was defined as a greater than 50% fall in 24-h urinary 17-oxogenic steroids. In the modern test, plasma cortisol is measured at 0 and 48 h or, less commonly, plasma cortisol is measured at 08. In both these tests, greater than 50% suppression of plasma cortisol in comparison with the basal sample has been used to define a positive response. Calcitonin, chromogranin A, and gut hormones such as gastrin and vasoactive intestinal polypeptide should be measured for assessment of secretion from neuroendocrine tumours. However, if mistakes are to be avoided it is essential that full biochemical assessment takes place prior to imaging and the results of any imaging technique must always be interpreted in the light of the biochemical results. The classical features of a pituitary microadenoma are a hypodense lesion after contrast and a convex upper surface of the pituitary gland. Once again, adrenal incidentalomas are present in up to 5% of normal subjects (this number increases with age), and thus adrenal imaging should not be performed unless biochemical investigation suggests a primary adrenal cause. Adrenal carcinomas are large and often associated with metastatic spread at presentation. Adrenal causes Adrenal adenomas should be removed by unilateral adrenalectomy, which has a 100% cure rate. Laparoscopic adrenalectomy is now the surgical treatment of choice for unilateral adenomas as it reduces surgical morbidity and postoperative hospital stay compared with open approaches. To assess if the contralateral adrenal gland has recovered from suppression intermittent measurement of the 08. When the morning plasma cortisol is above 180 nmol/litre a stimulation test such as the Synacthen test (250 mcg), may then demonstrate whether the contralateral adrenal gland has recovered from its suppression. Before the selective removal of a pituitary microadenoma became routine, the treatment of choice was bilateral adrenalectomy. Even with modern management, an increased prevalence of cardiovascular risk factors persists for many years. These patients required lifelong replacement therapy with hydrocortisone and fludrocortisone. After selective removal of a microadenoma, the surrounding corticotrophs are normally suppressed. However, remission is generally considered likely if morning serum/plasma cortisol is less than 138 nmol/litre (5µg/dl) and/or urinary free cortisol less than 28­56 nmol/24 hours (<10­20 µg/24 hours) within 7 days of surgery, but a number of alternative cut-offs have been suggested. Patients who are eucortisolaemic following surgery may still have residual tumours, even though cortisol secretion may have fallen to normal or subnormal values. In such patients the return of a normal circadian rhythm (as demonstrated by the finding of low midnight salivary cortisol levels) is helpful in assessing disease control.

Buy trimethoprim 480 mg online. Antimicrobial resistance in humans livestock and the wider environment.

References